Hospital
Greenwood Leflore Hospital
Greenwood Leflore Hospital was paid $31.89M by Medicaid between Jan 2018 and Dec 2024, across 316 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoGREENWOOD LEFLORE HOSPITAL
GREENWOOD, MS 38930
GREENWOOD, MS 38930
33aNPI1699714717assigned 06/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$31.89M
24GClaims858,943
24DCodes billed316
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#16 of 77
Median peer was paid$8.23M
This provider vs. median3.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HOLMES, DAWNE controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 174,755 | $6.28M | |
| 2019 | 179,196 | $6.74M | |
| 2020 | 132,654 | $4.57M | |
| 2021 | 123,983 | $4.49M | |
| 2022 | 112,284 | $4.11M | |
| 2023 | 79,918 | $3.31M | |
| 2024incomplete | 56,153 | $2.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 57,040 | 46,218 | $6.91M |
| G0378 | Hospital observation service, per hour | 7.9% | 8,849 | 6,393 | $2.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.5% | 17,274 | 14,380 | $2.39M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.4% | 13,110 | 8,822 | $1.10M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 23,147 | 4,419 | $843K |
| 36902 | 2.6% | 802 | 647 | $843K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 9,495 | 8,241 | $758K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2.4% | 7,768 | 4,613 | $755K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.3% | 12,890 | 2,698 | $723K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 19,820 | 13,875 | $674K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.0% | 3,809 | 3,195 | $629K |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 13,041 | 11,339 | $552K |
304 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 2,991 | $470K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 12,486 | $448K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 2,294 | $429K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1.3% | 15,440 | $418K |
| 59025 | Fetal non-stress test | 1.3% | 4,389 | $407K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 17,928 | $367K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.1% | 1,278 | $356K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 8,649 | $315K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,702 | $308K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 53,713 | $302K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 5,257 | $281K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,312 | $259K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 20,366 | $246K |
| 36821 | <1% | 330 | $236K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 16,305 | $232K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 8,253 | $231K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 8,257 | $230K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,796 | $224K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,756 | $224K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 34,907 | $224K |
| 86900 | <1% | 3,825 | $223K | |
| 36832 | <1% | 259 | $220K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 533 | $176K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,820 | $173K |
| 74018 | <1% | 4,107 | $171K | |
| 74019 | <1% | 2,710 | $168K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,756 | $165K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 3,664 | $154K |
| 80053 | Comprehensive metabolic panel | <1% | 19,084 | $152K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 431 | $151K |
| 36905 | <1% | 148 | $146K | |
| J2997 | Injection, alteplase recombinant, 1 mg | <1% | 248 | $132K |
| 73564 | <1% | 2,018 | $129K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,445 | $126K |
| 36600 | <1% | 3,118 | $125K | |
| 83880 | <1% | 4,850 | $124K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 2,123 | $116K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,344 | $112K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 328 | $109K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,597 | $109K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 10,601 | $109K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,482 | $108K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,465 | $104K |
| 84484 | <1% | 9,951 | $103K | |
| 80061 | Lipid panel | <1% | 8,433 | $95K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 331 | $95K |
| 86850 | <1% | 3,489 | $94K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,252 | $82K |
| 93931 | <1% | 2,227 | $79K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 771 | $75K |
| 20553 | <1% | 866 | $71K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 436 | $70K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,225 | $65K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 855 | $59K |
| 82803 | <1% | 3,522 | $59K | |
| 80306 | <1% | 4,923 | $59K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 606 | $59K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,829 | $57K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,146 | $57K |
| 97161 | <1% | 1,136 | $54K | |
| 87660 | <1% | 3,952 | $54K | |
| 87480 | <1% | 3,950 | $52K | |
| 73030 | <1% | 1,360 | $52K | |
| 87040 | <1% | 4,893 | $51K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 134 | $51K |
| 87510 | <1% | 3,948 | $50K | |
| 88142 | <1% | 2,980 | $50K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 686 | $50K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 663 | $50K |
| 72100 | <1% | 862 | $48K | |
| 83655 | <1% | 4,192 | $47K | |
| 97162 | <1% | 851 | $46K | |
| 76801 | <1% | 690 | $45K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,755 | $45K |
| 73630 | <1% | 1,058 | $45K | |
| 87536 | <1% | 673 | $44K | |
| 72110 | <1% | 755 | $43K | |
| 93017 | <1% | 688 | $42K | |
| 84702 | <1% | 3,924 | $41K | |
| 73610 | <1% | 939 | $41K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,573 | $40K |
| 88312 | <1% | 1,355 | $39K | |
| 85027 | <1% | 8,366 | $39K | |
| 86780 | <1% | 3,699 | $39K | |
| 88304 | <1% | 1,184 | $35K | |
| 83605 | <1% | 4,348 | $34K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 773 | $33K |
| 81025 | <1% | 5,283 | $31K | |
| 83735 | <1% | 6,865 | $31K | |
| 80076 | <1% | 4,997 | $30K | |
| 76830 | Ultrasound, transvaginal | <1% | 447 | $30K |
| 62322 | <1% | 257 | $28K | |
| 83690 | <1% | 5,483 | $28K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 219 | $28K |
| 73130 | <1% | 709 | $28K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,647 | $27K |
| 85610 | <1% | 9,483 | $26K | |
| 87807 | <1% | 2,465 | $26K | |
| 86922 | <1% | 233 | $25K | |
| 97165 | <1% | 580 | $25K | |
| 85379 | <1% | 3,723 | $25K | |
| 84703 | <1% | 4,355 | $25K | |
| 86762 | <1% | 2,066 | $23K | |
| 87077 | <1% | 3,632 | $23K | |
| 86140 | <1% | 5,990 | $23K | |
| 81001 | <1% | 10,937 | $22K | |
| 87081 | <1% | 4,194 | $22K | |
| 86703 | <1% | 1,949 | $22K | |
| 73502 | <1% | 654 | $22K | |
| 87186 | <1% | 3,166 | $21K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 328 | $21K |
| 81003 | <1% | 14,241 | $20K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 429 | $20K |
| 72050 | <1% | 340 | $19K | |
| 87340 | <1% | 2,363 | $18K | |
| 11721 | <1% | 943 | $18K | |
| 76642 | <1% | 480 | $18K | |
| 85730 | <1% | 4,316 | $17K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 57 | $17K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $16K |
| 86361 | <1% | 615 | $14K | |
| 93971 | <1% | 344 | $14K | |
| 77336 | <1% | 206 | $13K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 153 | $13K |
| 82731 | <1% | 256 | $13K | |
| 87070 | <1% | 1,759 | $13K | |
| 84550 | <1% | 3,352 | $12K | |
| 86787 | <1% | 590 | $12K | |
| 73110 | <1% | 295 | $12K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 30 | $12K |
| 76770 | <1% | 229 | $11K | |
| 97016 | <1% | 1,478 | $11K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 150 | $10K |
| 77066 | Tomosynthesis, mammo | <1% | 157 | $10K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 159 | $10K |
| 73590 | <1% | 234 | $10K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 290 | $9K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 74 | $9K |
| 85660 | <1% | 2,114 | $9K | |
| 70486 | <1% | 156 | $9K | |
| 82274 | <1% | 793 | $9K | |
| 82950 | <1% | 2,304 | $9K | |
| 36430 | <1% | 101 | $8K | |
| 82105 | <1% | 669 | $8K | |
| 82652 | <1% | 395 | $7K | |
| 97116 | <1% | 546 | $7K | |
| 75822 | <1% | 13 | $7K | |
| 86592 | <1% | 1,813 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 66 | $6K |
| 82677 | <1% | 355 | $6K | |
| 93970 | <1% | 81 | $6K | |
| 92523 | <1% | 44 | $6K | |
| 82553 | <1% | 581 | $6K | |
| 82550 | <1% | 1,020 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 267 | $6K |
| 10060 | <1% | 60 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 6,541 | $5K |
| 87428 | <1% | 145 | $5K | |
| 82728 | <1% | 478 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 9,420 | $5K |
| 86336 | <1% | 355 | $5K | |
| 87400 | <1% | 1,244 | $5K | |
| 85045 | <1% | 1,360 | $5K | |
| 84153 | <1% | 269 | $4K | |
| 82947 | <1% | 1,366 | $4K | |
| 82565 | <1% | 997 | $4K | |
| 84439 | <1% | 647 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 31 | $4K |
| 64417 | <1% | 249 | $4K | |
| 80305 | <1% | 400 | $4K | |
| 36589 | <1% | 29 | $4K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $4K |
| 82248 | <1% | 819 | $4K | |
| 77300 | <1% | 28 | $3K | |
| 85652 | <1% | 1,606 | $3K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 22 | $3K |
| 86694 | <1% | 277 | $3K | |
| 73560 | <1% | 68 | $3K | |
| 73080 | <1% | 68 | $3K | |
| 86695 | <1% | 264 | $3K | |
| 11043 | <1% | 16 | $3K | |
| 83550 | <1% | 356 | $2K | |
| 93798 | <1% | 88 | $2K | |
| 82150 | <1% | 371 | $2K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 1,778 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 154 | $2K |
| 36558 | <1% | 19 | $2K | |
| 87046 | <1% | 115 | $2K | |
| 80177 | <1% | 193 | $2K | |
| 81015 | <1% | 3,068 | $2K | |
| 82570 | <1% | 476 | $2K | |
| 82607 | <1% | 129 | $2K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 107 | $2K |
| 87187 | <1% | 115 | $2K | |
| 20610 | <1% | 15 | $1K | |
| 76775 | <1% | 32 | $1K | |
| 73090 | <1% | 40 | $1K | |
| 87906 | <1% | 24 | $1K | |
| 84156 | <1% | 494 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 54 | $1K |
| 77065 | Tomosynthesis, mammo | <1% | 32 | $1K |
| 83615 | <1% | 243 | $1K | |
| 80074 | <1% | 29 | $1K | |
| 29125 | <1% | 13 | $953.59 | |
| 94010 | <1% | 12 | $942.32 | |
| 72072 | <1% | 22 | $930.82 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 885 | $925.20 |
| 97760 | <1% | 60 | $894.41 | |
| 73552 | <1% | 21 | $710.08 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $685.81 |
| 82009 | <1% | 162 | $629.98 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 44 | $600.44 |
| 83540 | <1% | 95 | $589.53 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | <1% | 875 | $588.88 |
| 84460 | <1% | 181 | $587.38 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 808 | $580.80 |
| 93225 | <1% | 12 | $557.02 | |
| 70210 | <1% | 12 | $555.25 | |
| 84132 | <1% | 146 | $530.02 | |
| 82044 | <1% | 112 | $516.65 | |
| 73221 | <1% | 14 | $502.64 | |
| 93880 | <1% | 12 | $443.92 | |
| 85384 | <1% | 61 | $360.35 | |
| 87205 | <1% | 119 | $305.76 | |
| 82010 | <1% | 58 | $279.30 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 7,505 | $276.30 |
| 84450 | <1% | 86 | $268.26 | |
| 80185 | <1% | 17 | $250.24 | |
| 82575 | <1% | 29 | $231.02 | |
| A4450 | Tape, non-waterproof, per 18 square inches | <1% | 1,587 | $228.09 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 18 | $206.70 |
| 86308 | <1% | 44 | $203.37 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 68 | $180.94 |
| 86803 | <1% | 13 | $171.35 | |
| 80164 | <1% | 14 | $170.66 | |
| 82043 | <1% | 39 | $158.53 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 2,010 | $157.00 |
| A6196 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing | <1% | 2,630 | $149.48 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 780 | $134.80 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,370 | $112.00 |
| 84436 | <1% | 16 | $85.85 | |
| 86156 | <1% | 13 | $84.63 | |
| 00731 | <1% | 1,439 | $81.00 | |
| 82270 | <1% | 27 | $65.88 | |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 1,973 | $59.92 |
| 85007 | <1% | 27 | $59.35 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,324 | $51.39 |
| 00812 | <1% | 324 | $40.05 | |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | <1% | 230 | $39.68 |
| 80320 | <1% | 1,208 | $16.66 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,294 | $13.86 |
| 00811 | <1% | 1,097 | $11.40 | |
| 01844 | <1% | 1,134 | $11.40 | |
| 00400 | <1% | 16 | $8.55 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 98 | $0.00 |
| G0475 | Hiv antigen/antibody, combination assay, screening | 0% | 2,987 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 19 | $0.00 |
| A6213 | Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing | 0% | 359 | $0.00 |
| 94760 | 0% | 1,407 | $0.00 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 1,101 | $0.00 |
| 96376 | 0% | 4,077 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 630 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 1,022 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 205 | $0.00 |
| C1769 | Guide wire | 0% | 2,645 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 1,076 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 181 | $0.00 |
| A6450 | Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard | 0% | 347 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 32 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 66 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 621 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 17 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 66 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 24 | $0.00 |
| 01400 | 0% | 12 | $0.00 | |
| A6260 | Wound cleansers, any type, any size | 0% | 87 | $0.00 |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 0% | 158 | $0.00 |
| 80329 | 0% | 12 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 146 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 113 | $0.00 |
| A6252 | Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing | 0% | 40 | $0.00 |
| C1750 | Catheter, hemodialysis/peritoneal, long-term | 0% | 45 | $0.00 |
| C1768 | Graft, vascular | 0% | 40 | $0.00 |
| 88141 | 0% | 20 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 1,526 | $0.00 |
| 99152 | 0% | 244 | $0.00 | |
| C1752 | Catheter, hemodialysis/peritoneal, short-term | 0% | 372 | $0.00 |
| A6446 | Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard | 0% | 1,034 | $0.00 |
| 84145 | 0% | 2,382 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 197 | $0.00 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 12 | $0.00 |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 0% | 14 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 493 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 488 | $0.00 |
| 76937 | 0% | 62 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 116 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 160 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 74 | $0.00 |
| A6199 | Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches | 0% | 26 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 30 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 47 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 17 | $0.00 |
| 36005 | 0% | 13 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLMES, DAWNE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Greenwood Leflore Hospital | Greenwood, MS | $4.73M |
| Greenwood Leflore Hospital | Greenwood, MS | $1.92M |
| Greenwood Leflore Hospital | Greenwood, MS | $1.10M |
| Greenwood Leflore Hospital | Greenwood, MS | $857K |
| Greenwood Leflore Hospital | Greenwood, MS | $767K |
| Greenwood Leflore Hospital | Greenwood, MS | $522K |
| Greenwood Leflore Hospital | Greenwood, MS | $473K |
| Greenwood Leflore Hospital | Greenwood, MS | $401K |
| Greenwood Leflore Hospital | Greenwood, MS | $230K |
| Greenwood Leflore Hospital | Greenwood, MS | $216K |
| Greenwood Leflore Hospital | Greenwood, MS | $176K |
| Greenwood Leflore Hospital | Greenwood, MS | $101K |
| Greenwood Leflore Hospital | Greenwood, MS | $97K |
| Greenwood Leflore Hospital | Greenwood, MS | $87K |
| Greenwood Leflore Hospital | Kilmichael, MS | $78K |
| Greenwood Leflore Hospital | Greenwood, MS | $55K |
| Greenwood Leflore Hospital | Greenwood, MS | $44K |
| Greenwood Leflore Hospital | Greenwood, MS | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.